A Pilot Study Of Riluzole In Patients With Post Traumatic Stress Disorder (PTSD)

Summary

This open label study will evaluate the safety and efficacy of riluzole in patients with PTSD. Patients will receive riluzole 50mg twice per day orally for 12 weeks as outpatient, with a one month follow up at week 16.

Timeline

Start

2014-01

Primary completion

2020-01

Completion

2020-01

Drugs

Indications